Clinical trial Recruiting at 1 site Observational Ages 18 and up

Diagnostic journey and treatment disparities for adults with spinal muscular atrophy at MedStar Health

Official title: Understanding the Diagnostic Pathway and Treatment Experience of Patients With Spinal Muscular Atrophy (SMA)

Run by Medstar Health Research Institute · NCT07223489 · Data updated 2026-11-12

This project will see how adults with spinal muscular atrophy in the MedStar Health system experienced diagnosis, access to approved SMA therapies, and barriers to care.

More Spinal Muscular Atrophy (SMA) trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorMedstar Health Research Institute
Academic / other
Locations1 site (Washinton, District of Columbia)
StatusRecruiting
StartedOctober 10, 2025
Main results expectedJune 30, 2026
Study endsDecember 30, 2026
Registry record updatedJanuary 16, 2026
Trial IDNCT07223489 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are adults (age ≥18) with a confirmed diagnosis of SMA who receive care within the MedStar Health system and can complete a one-hour telephone interview.

Probably not a fit

Patients who are deceased, under 18, receive care outside MedStar Health, or are unable to complete a telephone interview are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project uses a two-phase approach to document diagnostic timelines, genetic testing, treatment history, and demographic factors for adults with SMA treated within the MedStar Health system. Phase 1 is a retrospective chart review of up to 200 patients to identify patterns of diagnosis, genetic confirmation, and treatment uptake. Phase 2 invites eligible adults to one 60-minute telephone interview to discuss their diagnostic experiences, understanding of SMA, access to therapies, and barriers encountered. The combined data will be used to describe disparities in treatment and care coordination within this regional health system.

Why it matters

Potential benefit: If successful, the findings could reveal specific gaps in diagnosis and access and guide interventions to improve timely treatment and equity for adults with SMA.

How similar studies have gone: Retrospective chart reviews and qualitative interviews have been used in SMA research before and have identified diagnostic delays and treatment access disparities, so this approach is established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* SMA diagnosis, age greater than or equal to 18 years

Exclusion Criteria:

* Deceased

Where it's running

  • MedStar Health Research Institute
    Washinton, District of Columbia, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.